Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

Market Cap	40.09B
Revenue (ttm)	77.54B
Net Income (ttm)	2.99B
Shares Out	1.63B
EPS (ttm)	1.84
PE Ratio	14.06
Forward PE	13.79
Dividend	0.80 (3.08%)
Ex-Dividend Date	Sep 12, 2025

Volume	10,088,139
Average Volume	10,234,715
Open	25.96
Previous Close	25.94
Day's Range	25.79 - 26.02
52-Week Range	24.56 - 29.64
Beta	0.29
RSI	43.62
Earnings Date	Mar 16, 2026

About SHA:600332

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1997
• Employees: 28,048
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600332

Financial Performance

In 2024, SHA:600332's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.